Angela Boudreau
YOU?
Author Swipe
View article: Functional Recovery and Return to Duty Following Minimally Invasive Surgery for Hallux Valgus: A Retrospective Review in Active-Duty Military Personnel
Functional Recovery and Return to Duty Following Minimally Invasive Surgery for Hallux Valgus: A Retrospective Review in Active-Duty Military Personnel Open
Background: Hallux valgus can severely limit physical function in demanding professions like military service. Traditional open surgeries have shown limited success in achieving rapid recovery and full functional return. The primary object…
View article: Identifying Therapeutic Targets for Complex Notch1 Mutations of Hypoplastic Left Heart Syndrome
Identifying Therapeutic Targets for Complex Notch1 Mutations of Hypoplastic Left Heart Syndrome Open
View article: SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience
SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience Open
Patients with cancer are more vulnerable to severe COVID-19. As a result, routine SARS-CoV-2 testing of asymptomatic patients with cancer is recommended prior to treatment. However, there is limited evidence of its clinical usefulness. The…
View article: Practical considerations for the integration of subcutaneous targeted therapies into the oncology clinic.
Practical considerations for the integration of subcutaneous targeted therapies into the oncology clinic. Open
The oncology clinic is changing, with an increasing number of cancer therapies becoming available as formulations for subcutaneous (SC) injection. Using targeted therapies, such as alemtuzumab, bortezomib, rituximab or trastuzumab, via SC …
View article: PROLONGED MOLECULAR AND CLINICAL REMISSIONS IN FOLLICULAR LYMPHOMA PATIENTS TREATED WITH HDT/ASCT AND COMBINATION IMMUNOTHERAPY WITH RITUXIMAB AND INTERFERON α
PROLONGED MOLECULAR AND CLINICAL REMISSIONS IN FOLLICULAR LYMPHOMA PATIENTS TREATED WITH HDT/ASCT AND COMBINATION IMMUNOTHERAPY WITH RITUXIMAB AND INTERFERON α Open
Introduction: Follicular lymphoma is an indolent disease with a relapsing remitting course and shorter remission periods with each successive treatment. The median PFS and OS for patients who relapse within 12 m of prior therapy are 13 m a…
View article: Follow-Up Care for Survivors of Lymphoma Who Have Received Curative-Intent Treatment
Follow-Up Care for Survivors of Lymphoma Who Have Received Curative-Intent Treatment Open
Objective: This evidence summary set out to assess the available evidence about the follow-up of asymptomatic survivors of lymphoma who have received curative-intent treatment. Methods: The MEDLINE and EMBASE databases and the Cochrane Dat…